Mesoblast Limited (MESO) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 5 Buy, 4 Hold, 2 Sell.
The consensus price target is $11.50 (low: $11.00, high: $12.00), representing a downside of 21.3% from the current price $14.61.
Analysts estimate Earnings Per Share (EPS) of $-0.52 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.89 vs est $-0.52 (missed -70.2%). 2025: actual $-0.84 vs est $-0.59 (missed -42.4%). Analyst accuracy: 65%.
MESO Stock — 12-Month Price Forecast
$11.50
▼ -21.29% Downside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Mesoblast Limited, the average price target is $11.50, with a high forecast of $12.00, and a low forecast of $11.00.
The average price target represents a -21.29% change from the last price of $14.61.
Highest Price Target
$12.00
Average Price Target
$11.50
Lowest Price Target
$11.00
MESO Analyst Ratings
Buy
Based on 11 analysts giving stock ratings to Mesoblast Limited in the past 3 months
EPS Estimates — MESO
65%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$0.89
vs Est –$0.52
▼ 41.2% off
2025
Actual –$0.84
vs Est –$0.59
▼ 29.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — MESO
86%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.006B
vs Est $0.007B
▼ 26.9% off
2025
Actual $0.017B
vs Est $0.018B
▼ 1.9% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
